Question 1: Where Is the Peptide Actually Manufactured?
Not "where does the company ship from" — where is the peptide synthesized? A distributor located in Miami or Houston may be distributing peptides synthesized in China or India and repackaged domestically. This is not US manufacturing. When you ask this question, accept only a specific answer: the name and address of the synthesis facility, plus an FDA facility registration number you can verify. If you receive a vague answer about "US-based partners" or "domestic processing," treat it as a red flag.
Question 2: What Does Their CoA Actually Include?
Request a sample CoA before your first order. A complete CoA for pharmaceutical-grade peptide API should include: an HPLC chromatogram (not just a purity percentage), a mass spectrometry report confirming molecular identity, lot-specific endotoxin testing (<1 EU/mg by LAL assay), and residual solvent analysis per ICH Q3C. A CoA that shows only "Purity: 99.1% — PASS" with no chromatogram or supporting data cannot be verified. That's not documentation — it's a number on paper.
Question 3: Do They Require License Verification?
A compliant wholesale peptide distributor should require proof of your pharmacy or medical license before fulfilling any order. If a distributor will sell to anyone who clicks "buy" — with no license verification, no application process, no account qualification — that tells you everything about how seriously they treat compliance. Their customer screening standards reflect their own compliance standards.
Question 4: What Is Their Endotoxin Testing Protocol?
Endotoxin testing is the most important safety test for injectable-grade peptide API, and it is also the most commonly skipped by non-compliant suppliers. Ask specifically: "Do you test every lot for endotoxins, and can you provide the actual test result (not just 'pass') for the lot you would ship to us?" A supplier who provides actual EU/mg results — not just a pass/fail notation — has a more mature quality system than one providing only binary results.
Question 5: What Is Their Supply Reliability Track Record?
Your clinical programs depend on consistent supply. Ask about: their typical lead time for your key products, whether they maintain finished inventory or manufacture to order, their out-of-stock history for the past 12 months, and what their protocol is when a product is temporarily unavailable. Reliable distributors maintain safety stock, communicate proactively about availability issues, and offer allocation guarantees to high-volume accounts.
Question 6: How Do They Handle Quality Issues?
Ask for their out-of-specification (OOS) investigation and customer notification protocol. What happens when a lot fails release testing? How is a customer notified if a lot they've already received is subsequently found to have issues? Do they issue lot recalls? A distributor who has never had a quality issue isn't necessarily trustworthy — it may mean they don't test thoroughly enough to find issues. A distributor with a clear, documented quality investigation and customer notification process is more credible than one claiming a perfect record.
Question 7: What Does Their Pricing Reflect?
We've addressed this in detail elsewhere, but it bears repeating: US synthesis in a legitimate ISO 5 cleanroom with full analytical testing has a cost floor. Pricing significantly below market without clear explanation should trigger the same questions as any other anomaly. Ask the distributor to walk you through what their pricing includes and whether the CoA documentation, supplier letters, and SDS are included or billed separately.
Frequently Asked Questions
Question 5: How Do They Handle Non-Conforming Lots?
Every legitimate peptide supplier will eventually ship a lot that fails to meet specifications — a CoA that reveals purity below threshold, an endotoxin result that exceeds the acceptable limit, or a mass spec result that identifies a structural variant. How a supplier responds to non-conforming lots is one of the clearest indicators of their quality culture. Ask directly: "What is your process when a lot fails analytical specifications?" A reputable supplier should have a documented non-conformance procedure, a clear replacement policy, and a communication protocol that notifies customers before shipment of a suspect lot.
Suppliers who dismiss this question or suggest that non-conforming lots never happen are not being truthful. Those who can describe their corrective action procedure with specificity — including root cause investigation, lot disposition, and customer notification — have invested in the quality infrastructure that protects your pharmacy or clinic from downstream compliance exposure.
Question 6: What Are Their Minimum Order Requirements and Payment Terms?
Wholesale peptide supplier minimums vary significantly — from single vial orders to multi-hundred vial minimums for wholesale pricing access. For small-to-medium clinic programs, minimums that exceed 30-day patient demand create unnecessary inventory risk and cash flow pressure. For large pharmacy programs, excessive flexibility in minimum orders may signal a supplier who cannot commit to production schedules. Understanding the economics of the supplier relationship matters for forecasting and budgeting.
Payment terms are similarly variable and worth negotiating. Net-30 terms are standard for established accounts with 3–6 months of order history. New accounts typically require prepayment or credit card payment. If a supplier offers unusually generous payment terms (Net-60 or Net-90) to new accounts without credit check, treat this as a potential red flag — it may signal that they are prioritizing order capture over financial prudence.
Question 7: Can They Provide References from Current Accounts?
A confident wholesale peptide supplier should be willing to provide references from current pharmacy or clinic accounts — particularly for new customers placing first-time orders above a certain threshold. References are most useful when you ask specific questions: "How consistently does this supplier meet your CoA standards?" "Have you experienced any documentation issues, and how were they resolved?" "How responsive is their account team when problems arise?"
Suppliers who decline to provide references, cite confidentiality reasons for every account, or offer only testimonials rather than direct contacts deserve additional scrutiny. The peptide wholesale market is relationship-driven; a supplier with strong accounts should be able to make warm introductions within their client base.
Building a Preferred Supplier Shortlist
Most mature pharmacy and clinic programs ultimately maintain relationships with 2–3 qualified peptide suppliers — a primary supplier for the majority of volume and backup suppliers for specific products or supply disruptions. Building this shortlist takes 6–12 months of active evaluation: placing sample orders, evaluating CoA documentation, testing account responsiveness, and verifying that pricing remains consistent with quoted rates. The shortlist approach reduces supply disruption risk while maintaining the documentation discipline of a concentrated, qualified supplier base.
What is the most important factor when choosing a wholesale peptide distributor?
Documentation quality. Lot-specific CoA with HPLC chromatogram, MS confirmation, endotoxin data, and residual solvents — from a verifiably US-manufactured source — is the non-negotiable foundation.
Should I use multiple peptide distributors or stick with one?
A single qualified primary distributor is preferable to splitting orders across lower-quality suppliers. Maintain a qualified backup supplier for high-volume products to protect against supply disruptions — but every supplier must meet the same documentation standards.
What compliance documentation should I request from a new peptide distributor?
Sample CoA with full analytical data, manufacturing facility address and FDA registration number, supplier letter, SDS for each product, and confirmation that they require license verification from all customers.